Integrin alpha-L (ITGAL) (Middle Region) Peptide
Quick Overview for Integrin alpha-L (ITGAL) (Middle Region) Peptide (ABIN5511047)
Target
Origin
Source
Application
-
-
Protein Region
- Middle Region
-
Sequence
- MSCTDFSFHF PVCVQDLISP INVSLNFSLW EEEGTPRDQR AQGKDIPPIL
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-ITGAL Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ITGAL (Integrin alpha-L (ITGAL))
-
Background
-
ITGAL encodes the integrin alpha L chain. Integrins are heterodimeric integral membrane proteins composed of an alpha chain and a beta chain. This I-domain containing alpha integrin combines with the beta 2 chain (ITGB2) to form the integrin lymphocyte function-associated antigen-1 (LFA-1), which is expressed on all leukocytes. LFA-1 plays a central role in leukocyte intercellular adhesion through interactions with its ligands, ICAMs 1-3 (intercellular adhesion molecules 1 through 3), and also functions in lymphocyte costimulatory signaling. Two transcript variants encoding different isoforms have been found for this gene.
Alias Symbols: CD11A, LFA-1, LFA1A
Protein Size: 1170 -
Gene ID
- 3683
-
NCBI Accession
- NM_001114380, NP_001107852
-
UniProt
- P20701
Target
-